ScholarIQanswers from OpenAlex

Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine

PaperCitations, authors & open-access status

Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine have?

ScholarIQcitation count

Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine has 86 citations in the OpenAlex counts ScholarIQ stores.

When was Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine published?

ScholarIQyear

Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine has 2021 year in the ScholarIQ index.

What is the open-access status of Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine?

ScholarIQoa status

Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine has gold oa status in the ScholarIQ index.

What is the DOI of Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine?

ScholarIQdoi

The DOI for Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine is on the source record.

What is the PMID of Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine?

ScholarIQpmid

The PMID for Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine is on the source record.

What is the OpenAlex record for Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine?

ScholarIQopenalex

The OpenAlex for Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial